Evidence map›Paper›PMID 36640211›Full record

ReviewCurrent psychiatry reports2023

Assessment and Treatment of Avoidant/Restrictive Food Intake Disorder.

P Evelyna Kambanis, Jennifer J Thomas

Open access · greenAbstract readReview
In one paragraph

Review in Current psychiatry reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Healthcare Professionals' Experiences of Barriers and Facilitators to ARFID Identification, Diagnosis and Treatment: A Rapid Review.European eating disorders review : the journal of the Eating Disorders Association · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Rethinking fussiness in commercial food contexts.Health promotion international · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

P Evelyna KambanisEating Disorders Clinical and Research Program, Massachusetts General Hospital, 2 Longfellow Place, Suite 200, Boston, MA, 02114, USA.ORCID 0000-0002-1950-3332
Jennifer J ThomasEating Disorders Clinical and Research Program, Massachusetts General Hospital, 2 Longfellow Place, Suite 200, Boston, MA, 02114, USA. jjthomas@mgh.harvard.edu.
Harvard University · US

Funding

Neurobiological Underpinnings of Avoidant/Restrictive Food Intake Disorder in AdultsR01MH128246 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI LAURA McGrath HOLSEN, Elizabeth Austen Lawson · 2022 to 2026
$4.5M
Neurobiological and Behavioral Risk Mechanisms of Youth Avoidant/Restrictive Eating TrajectoriesR01MH108595 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI LAWSON, ELIZABETH AUSTEN, MICALI, NADIA · 2016 to 2020
$3.4M
NIMH NIH HHS R01 MH108595NIMH NIH HHS R01 MH128246
6 · The paper itself

Abstract

purpose of reviewTo review the literature pertaining to the assessment and treatment of avoidant/restrictive food intake disorder (ARFID) ten years following its introduction to DSM-5. RECENT

findingsSeveral structured clinical interviews for assessing ARFID have been developed, each with its own strengths and limitations. There is no clear leading self-report measure for tracking treatment progress and outcome in ARFID. Medical assessment is comprised of examining anthropometrics, vitamin deficiencies, and other comorbidities. To date, several studies have reported on cognitive behavioral therapy, family-based treatment, and other approaches to the treatment of ARFID. These treatments appear promising; however, they rely on data from clinical case series and very small randomized controlled trials. Several promising assessments and treatments for ARFID are in the early stages of research. Yet, controversies remain. These include (a) overlap with criteria for pediatric feeding disorder; (b) the optimal method for assessing nutrient deficiencies; (c) disciplines involved in treatment. Future research innovation is necessary to improve the psychometric properties of ARFID assessments and evaluate treatment efficacy with larger samples and randomized designs.

Indexed as

Avoidant Restrictive Food Intake DisorderFeeding and Eating DisordersChildComorbidityEatingHumansTreatment OutcomeARFIDAssessmentAvoidant/restrictive food intake disorderCBT-ARCognitive behavioral therapy for ARFIDFamily-based treatment for ARFIDFBT-ARFIDFear of aversive consequencesNutritional deficienciesPediatric feeding disorderPsychosocial impairmentSensory sensitivityTreatment

Identifiers

PMID36640211
PMCPMC10211369
OpenAlexW4316094594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.